There are isolated reports of overdose with fulvestrant in humans. If overdose occurs, symptomatic supportive treatment is recommended. Animal studies suggest that no effects other than those related directly or indirectly to antiestrogenic activity were evident with higher doses of fulvestrant.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
